This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Herbert Y. Meltzer, MD
Department of Psychiatry Case Western Reserve University 2040 Abington Rd Cleveland, OH 44106

Arch Gen Psychiatry. 1990;47(3):291.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—

Dr Fink states that 70% of the cases treated by the Clozaril Collaborative Study Group¹ were failures after 6 weeks of treatment and might be better assigned to a trial of ECT plus neuroleptic. The point of my letter was that my clinical experience with clozapine provides abundant evidence that a number of treatmentresistant schizophrenic patients who have not responded to clozapine by 6 weeks will respond, sometimes dramatically, at subsequent periods. In my view, such patients should not be considered clozapine failures if there is no improvement by 6 weeks, but rather as possible responders who have not yet had an adequate trial. In short, just as clozapine clearly differs from typical neuroleptics in efficacy and side effects, it also differs in time course. I strongly believe that it is erroneous to apply the customary 6week trial period used for typical neuroleptic drugs to clozapine, based on . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?